Aquatic Capital Management LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1803916 CHICAGO, IL

Position in ALNY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,277,153

-$28,053,751 QoQ

Shares Held

31,061

-63.0% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.30%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Aquatic Capital Management LLC holds $123,092,373 across 91 Biotechnology names. ALNY ranks #2 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	147,379	$11,066,689
2	ALNY	Alnylam Pharmaceuticals, Inc. This page	31,061	$10,277,153
3	EXEL	Exelixis, Inc.	194,571	$8,345,150
4	RPRX	Royalty Pharma plc	127,227	$6,103,079
5	ARWR	Arrowhead Pharmaceuticals, Inc.	80,227	$5,030,232
6	CYTK	Cytokinetics Inc	72,478	$4,777,024
7	XENE	Xenon Pharmaceuticals Inc.	79,199	$4,605,421
8	NKTR	Nektar Therapeutics	57,014	$4,102,157

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,277,153	31,061	-63.0%	Shares	Sole	2026-05-15
2025-09-30	$38,330,904	84,059	+485.9%	Shares	Sole	2025-11-14
2025-03-31	$3,874,246	14,348	-64.6%	Shares	Sole	2025-05-15
2024-12-31	$9,542,291	40,552	+98.7%	Shares	Sole	2025-02-14
2024-09-30	$5,613,087	20,409	+537.8%	Shares	Sole	2024-11-14
2024-06-30	$777,600	3,200	-85.3%	Shares	Sole	2024-08-14
2024-03-31	$3,258,010	21,800	+4.3%	Shares	Sole	2024-05-15
2023-12-31	$4,000,469	20,900	+16.8%	Shares	Sole	2024-02-14
2023-09-30	$3,170,090	17,900	-16.0%	Shares	Sole	2023-11-14
2023-03-31	$4,266,816	21,300	+10550.0%	Shares	Sole	2023-05-15
2022-03-31	$32,658	200	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.